The effECT (cas 13373-97-2) of elECT (cas 13373-97-2)roconvulsive therapy (ECT (cas 13373-97-2)) on serum tryptophan metabolites

Add time:07/24/2019    Source:sciencedirect.com

BackgroundPrior studies suggest that activation of the tryptophan catabolism via the kynurenine pathway by proinflammatory cytokines may be involved in the pathophysiology of depression. Electroconvulsive therapy (ECT) is an effective treatment for major depression (MD) with immunomodulation as one of the proposed modes of action.

We also recommend Trading Suppliers and Manufacturers of ECT (cas 13373-97-2). Pls Click Website Link as below: cas 13373-97-2 suppliers

Prev:Highly stereoselective synthesis of new α-amino-β-hydroxy six-membered heterocyclic phosphonic acids, serine analogues
Next:MMSE Changes During and After ECT (cas 13373-97-2) in Late-Life Depression: A ProspECT (cas 13373-97-2)ive Study)